Sangamo BioSciences, Inc. - Financial and Strategic Analysis Review
Sangamo BioSciences, Inc. - Financial and Strategic Analysis Review
Summary
Sangamo BioSciences, Inc. (Sangamo) is a developmental stage biotechnology company engaged in the development and commercialization of zinc finger DNA-binding proteins (ZFPs), transcription factors for gene regulation and gene modification. The company has The Company‘s lead candidate on its product pipeline is the SB-509 an injectable plasmid formulation of a ZFP TF activator of the vascular endothelial growth factor-A gene and EW-A-401 that contains the same ZFP TF as SB-509 but targets peripheral artery diseases.The company has its operation across the US. The company is headquartered in Richmond, California and employs around 83 employees.
Global Markets Direct, the leading business information provider, presents an in-depth business, strategic and financial analysis of Sangamo BioSciences, Inc.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis and Global Markets Direct’s views on the company.
Scope
-The company’s strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
-The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
-The report contains critical company information – business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
-It provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
-Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Reasons to buy
-A quick “one-stop-shop” to understand the company.
-Enhance business/sales activities by understanding customers’ businesses better.
-Get detailed information and financial & strategic analysis on companies operating in your industry.
-Identify prospective partners and suppliers – with key data on their businesses and locations.
-Capitalize on competitors’ weaknesses and target the market opportunities available to them.
-Compare your company’s financial trends with those of your peers / competitors.
-Scout for potential acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
RELATED REPORTS
Seattle Genetics, Inc. - Financial and Strategic Analysis ReviewSummarySeattle Genetics, Inc. (Seattle) is engaged in the discovery and the development of monoclonal antibody-based drugs to treat cancer and autoimmune diseases. It principally operates in the United States. The company is headquarte ...
Industries : Pharmaceutical
Anesiva, Inc. - Financial and Strategic Analysis ReviewSummaryAnesiva, Inc. (Anesiva) is engaged in development and commercialization of novel medicines for pain management. It is a biopharmaceutical company focusing on research and development of therapies for the treatment of post surgical pain, m ...
Industries : Pharmaceutical
Sepracor Inc. - Financial and Strategic Analysis ReviewSummarySepracor Inc. (Sepracor) is a research oriented pharmaceutical company that is principally engaged in the research, development, sales and marketing of products used in the treatment and prevention of human disease. The company is involve ...
Industries : Pharmaceutical
Vical Incorporated - Financial and Strategic Analysis ReviewSummaryVical Incorporated (Vical) is engaged in the research and development of biopharmaceutical products based on its patented DNA delivery technologies. The company also develops certain infectious disease vaccines and cancer therapeut ...
Industries : Pharmaceutical
Innogenetics NV - Financial and Strategic Analysis ReviewSummaryInnogenetics NV (Innogenetics) is a biopharmaceuticals company specialized in the areas of diagnostics and therapeutic vaccines. Its diagnostics business is engaged in the development of value-added products for infectious diseases, gen ...
Industries : Pharmaceutical
SkyePharma PLC - Financial and Strategic Analysis ReviewSummarySkyePharma PLC is a pharmaceutical company involved in R & D and manufacturing of drug delivery technologies, both for clinical studies and commercial sale. The company has eleven approved products in the areas of oral, inhalation and to ...
Industries : Pharmaceutical
Geron Corporation - Financial and Strategic Analysis ReviewSummaryGeron Corporation (Geron) is a biopharmaceuticals engaged developing new drugs for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure and diabetes. The company is advancing an anti-c ...
Industries : Pharmaceutical
MannKind Corporation - Financial and Strategic Analysis ReviewSummaryMannKind Corporation (MannKind) is a biopharmaceutical company engaged in the discovery, development, and commercialization of therapeutic products for diseases, such as diabetes and cancer. The company’s product pipeline include ...
Industries : Pharmaceutical
Ceapro Inc. - Financial and Strategic Analysis ReviewSummaryCeapro Inc. (Ceapro) is a biotechnology company. It is primarily engaged in the research, design and production of human and animal health care products. Ceapro is principally focused on developing a wide range of innovative active ingredie ...
Industries : Pharmaceutical
Clinical Data, Inc. - Financial and Strategic Analysis ReviewSummaryClinical Data, Inc. (Clinical Data) is engaged in providing complete molecular and pharmacogenomics services as well as clinical diagnostics to improve patient care. The company operates in North America, Europe and Asia. It is head ...
Industries : Pharmaceutical
Related industries
Related companies
reportlinker.com © Copyright 2010. All rights reserved